当前位置： SCI文献检索 > JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS期刊下所有文献 > Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia.

Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia.

Abstract：

OBJECTIVE:There is a growing interest in investigating the role of glutamate receptors in the pathophysiology of schizophrenia. Indeed, the hyperdopaminergic theory of schizophrenia can explain only the positive symptoms of schizophrenia, whereas the glutamate hypothesis may provide a more comprehensive view of the illness. We undertook a trial to investigate whether the combination of haloperidol with piracetam, a nootropic agent which modulates the glutamate receptor positively was more effective than haloperidol alone. METHODS:Thirty patients who met the DSM IV criteria for schizophrenia completed the study. Patients were allocated in a random fashion, 14 to haloperidol 30 mg/day plus piracetam 3200 mg/day and 16 to haloperidol 30 mg/day plus placebo. RESULTS:Although both protocols significantly decreased the score of the positive symptoms, the negative symptoms, the general psychopathological symptoms and the total score of PANSS scale over the trial period, the combination of haloperidol and piracetam showed a significant superiority over haloperidol alone in the treatment of schizophrenic patients. CONCLUSION:Piracetam, a member of the nootropic class of drugs and a positive modulator of glutamate receptor, may be of therapeutic benefit in treating schizophrenic patients in combination with typical neuroleptics. However, a larger study to confirm our results is warranted

journal_name

J Clin Pharm Ther

journal_title

Journal of clinical pharmacy and therapeutics

authors

Noorbala AA,Akhondzadeh S,Davari-Ashtiani R,Amini-Nooshabadi H

doi

10.1046/j.1365-2710.1999.00238.x

subject

Has Abstract

pub_date

1999-10-01 00:00:00

pages

369-74

issue

5

eissn

0269-4727

issn

1365-2710

pii

jcp238

journal_volume

24

pub_type

临床试验,杂志文章,随机对照试验

相关文献

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS文献大全
  • Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Vancomycin is the drug of choice for methicillin-resistant Staphylococcus aureus (MRSA) infection and shows time-dependent bacterial killing. The current study evaluated the pharmacokinetics (PK) and pharmacodynamics (PD) of vancomycin and explored its optimal dosing regimens by modeling and...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12123

    authors： Lim HS,Chong YP,Noh YH,Jung JA,Kim YS

    更新日期：2014-04-01 00:00:00

  • Management of sore throat in Polish primary care facilities: an example from the country with rare use of microbiological testing.

    abstract：OBJECTIVE:To describe sore throat management by primary care physicians in Poland. METHODS:We sent questionnaires to all primary care doctors in Podlaskie voievodship (north-eastern Poland) with clinical vignettes depicting patients with symptoms of sore throat. The probability of bacterial (streptococcal) infection w...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2007.00894.x

    authors： Chlabicz S,Pytel-Krolczuk B,Ołtarzewska AM,Marcinowicz L

    更新日期：2008-04-01 00:00:00

  • Ceftriaxone-associated renal toxicity in adults: a case report and recommendations for the management of such cases.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Ceftriaxone is a third-generation cephalosporin with broad-spectrum antibacterial activity. Ceftriaxone-associated urolithiasis and post-renal acute renal failure (PARF) in adults is exceedingly rare and perhaps underappreciated. We report one such case to increase appreciation of this risk ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.12358

    authors： Shen-Hua W,Fan-Yi M,Qing-Ling Z,Li-Na Z,Li-Jun M

    更新日期：2016-06-01 00:00:00

  • Case report of perforation of an ileal neobladder after treatment of rectal cancer with bevacizumab and comment on mechanisms of intestinal perforation associated with bevacizumab.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) that has activity in several types of malignancies. One of the uncommon adverse effects is spontaneous bowel perforation. In patients who have undergone cystectomy, a loop of small bowel is often used...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2012.01343.x

    authors： Liu SV,Gollard R,Iqbal S

    更新日期：2012-10-01 00:00:00

  • Plasma transforming growth factor beta1 in breast cancer patients treated with CMF chemotherapy.

    abstract：BACKGROUND:In early breast cancer patients the transformed epithelial cells are thought to be sensitive to transforming growth factor beta1 (TGFbeta1)-mediated growth arrest. TGFbeta1 may therefore act as an anti-tumour promoter. However, in advanced breast cancer resistance to such TGFbeta1 action develops. Neoplastic...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.1365-2710.2000.00290.x

    authors： Kajdaniuk D,Marek B,Swietochowska E,Ostrowska Z,Glogowska-Szelag J,Kos-Kudla B,Ciesielska-Kopacz N,Wielkoszyski T

    更新日期：2000-08-01 00:00:00

  • Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Inhaled treprostinil represents an attractive alternative to the other available prostacyclin formulations by obviating the use of continuous infusions and its associated risks. Published evidence describing the process of transition from infusion prostacyclin therapy to inhaled treprostinil...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12170

    authors： Enderby CY,Soukup M,Al Omari M,Zeiger T,Burger C

    更新日期：2014-10-01 00:00:00

  • Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Based on extrapolation, biosimilar infliximab (IFX) was approved to treat inflammatory bowel disease (IBD). The first studies in adults have shown similar efficacy and safety in comparison with reference drug. The aim of this review was to collect and evaluate all the literature data regardi...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,评审

    doi：10.1111/jcpt.13239

    authors： Dipasquale V,Romano C

    更新日期：2020-12-01 00:00:00

  • Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Cancer patients treated with cisplatin chemotherapy frequently experience drug-induced nephrotoxicity. Clinical studies using a single chemotherapeutic regimen or large sample sizes for patients with the SLC22A2 808T allele have not been reported. Here, we examined 95 patients with oesophage...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12097

    authors： Hinai Y,Motoyama S,Niioka T,Miura M

    更新日期：2013-12-01 00:00:00

  • Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.

    abstract：OBJECTIVE:A large number of structurally and functionally diverse compounds act as substrates or modulators of p-glycoprotein (p-gp). Some of them possess multiple drug resistance (MDR)-reversing activity, but only a small number of them have entered clinical study. In order to uncover the factors which exert a signifi...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,评审

    doi：10.1046/j.1365-2710.2003.00487.x

    authors： Wang RB,Kuo CL,Lien LL,Lien EJ

    更新日期：2003-06-01 00:00:00

  • Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.

    abstract：WHAT IS KNOWN AND OBJECTIVE:The CHOP regimen with rituximab (R-CHOP) remains the standard for chemotherapy in patients with aggressive non-Hodgkin's lymphoma (NHL). The cardiotoxicity of doxorubicin appears to be a key problem in clinical practice. We studied the cardiotoxicity of CHOP/R-CHOP regimen in a retrospective...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12124

    authors： Limat S,Daguindau E,Cahn JY,Nerich V,Brion A,Perrin S,Woronoff-Lemsi MC,Deconinck E

    更新日期：2014-04-01 00:00:00

  • Distribution of CYP2C19*17 allele and genotypes in an Indian population.

    abstract：WHAT IS KNOWN AND OBJECTIVE:CYP2C19*17 allele increases the metabolic activity of CYP2C19 resulting in decreased therapeutic levels of CYP2C19 substrates. There exist inter-ethnic differences in the distribution of this allele. The present study was aimed at establishing the allele and genotype frequencies of CYP2C19*1...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2011.01294.x

    authors： Anichavezhi D,Chakradhara Rao US,Shewade DG,Krishnamoorthy R,Adithan C

    更新日期：2012-06-01 00:00:00

  • Moringa oleifera leaf powder alters the pharmacokinetics of amodiaquine in healthy human volunteers.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Moringa oleifera (MO) Lam (Moringaceae) is commonly used as food supplement and as medicine in most African countries where malaria is also endemic. Therefore, co-administration of MO with antimalarials is a possibility. This study investigated the effects of MO leaves powder on the pharmaco...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12725

    authors： Olawoye OS,Adeagbo BA,Bolaji OO

    更新日期：2018-10-01 00:00:00

  • Drug compliance and the Morisky Adherence Scale: An expression of concern and a warning.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Every prescriber knows that patients often do not take their medicines as prescribed. Hippocrates, the wise man of Kos, knew over two millennia ago. Our objective is to comment on the types of studies aimed at understanding and optimizing drug usage and to draw attention to the need to seek ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 社论

    doi：10.1111/jcpt.13325

    authors： Li-Wan-Po A,Peterson GM

    更新日期：2021-02-01 00:00:00

  • The effect of a residential care pharmacist on medication administration practices in aged care: A controlled trial.

    abstract：WHAT IS KNOWN AND OBJECTIVE:With the ageing of the population also comes increasing comorbidities and the use of multiple medications and administration methods, along with greater susceptibility to adverse drug reactions. Dosage form modification to facilitate drug administration in older adults can be potentially pro...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12822

    authors： McDerby N,Kosari S,Bail K,Shield A,Peterson G,Naunton M

    更新日期：2019-08-01 00:00:00

  • Adherence with naltrexone prescription advice in hospital outpatient alcohol rehabilitation programme.

    abstract：BACKGROUND:The anti-craving drug, naltrexone, is used as a pharmacotherapeutic adjunct in the treatment of alcohol dependence. In addictive disorders, compliance issues remain central. There are limited data on compliance with naltrexone treatment regimens within formalized rehabilitation programs and even less data th...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.1365-2710.2001.00326.x

    authors： Feeney GF,Connor JP,Young RM,Tucker J,Czajkowski F

    更新日期：2001-02-01 00:00:00

  • Evidence of frequent dosing errors in paediatrics and intervention to reduce such prescribing errors.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Drug prescribing is an essential part of inpatient care, and prescription errors/omissions have the potential to lead to disastrous consequences. Paediatric inpatient prescribing is particularly sensitive to error due to the weight-adjusted dosing of many medications prescribed in the acute ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12114

    authors： Bolt R,Yates JM,Mahon J,Bakri I

    更新日期：2014-02-01 00:00:00

  • Extremely low dose of 6-mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations.

    abstract：WHAT IS KNOWN AND OBJECTIVES:Thiopurines are cornerstone drugs in the treatment of acute lymphoblastic leukaemia (ALL), but their use can be complicated by the incidence of life-threatening leucopenia. CASE DESCRIPTION:We describe a case of a 6-year-old Chinese boy with B-ALL receiving extremely low dose of 6-mercapto...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.13255

    authors： Zhai XY,Zhou Y,Dong L,Nie AQ,Zhi LJ,Jacqz-Aigrain E,Wang TY,Wang L,Zhao W

    更新日期：2021-02-01 00:00:00

  • Theophylline plasma clearance in critically ill geriatric patients receiving total parenteral nutrition and in control patients.

    abstract：:Mean values and standard deviations are reported for theophylline plasma clearance in 45 hospitalized geriatric patients (age greater than 65 years), distributed into two groups: Group I (n = 24) included critically ill patients admitted to the ICU on total parenteral nutrition (TPN). Group II (n = 21) included patien...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.1990.tb00385.x

    authors： Sangrador G,Sánchez-Alcaraz A,Ubeda R,Ibañez P

    更新日期：1990-08-01 00:00:00

  • The use of prescription drugs among elderly Finnish men.

    abstract：:The extent and factors that influence drug use were studied in two rural cohorts of Finnish men. The men aged between 65 and 84 years belonged to the Finnish study population of the 25-year follow-up of the 'Seven Countries Study'. Of the original 1,711 men in 1959, 766 were still alive in 1984. The participation rate...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.1990.tb00365.x

    authors： Enlund H,Martikainen J,Turakka H,Nissinen A

    更新日期：1990-04-01 00:00:00

  • Lithium reduces maternal child abuse behaviour: a preliminary report.

    abstract：OBJECTIVE:To find out in child abusing mothers whether aggressiveness in general, but which is directed towards their children in particular, could be reduced by giving lithium. METHOD:An open trial of lithium in eight child-abusing mothers. Assessment of aggression using Yudofsky's Overt Aggression Scale. RESULTS:Th...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 临床试验,杂志文章

    doi：10.1046/j.1365-2710.2001.00357.x

    authors： do Prado-Lima P,Knijnik L,Juruena M,Padilla A

    更新日期：2001-08-01 00:00:00

  • Population pharmacokinetic investigation of digoxin in Japanese neonates.

    abstract：OBJECTIVE:To establish the role of patient characteristics in estimating doses of digoxin for neonates using routine therapeutic drug monitoring data. METHOD:The steady-state blood level data (n = 129) after repetitive oral administration in 71 hospitalized neonates were analysed using Nonlinear Mixed Effects Modellin...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2007.00833.x

    authors： Yukawa E,Akiyama K,Suematsu F,Yukawa M,Minemoto M

    更新日期：2007-08-01 00:00:00

  • Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care.

    abstract：OBJECTIVE:To evaluate the usefulness of intervention in drug interactions of antiretroviral drugs with coadministered agents by a clinical pharmacist in outpatient HIV-treatment. METHODS:The study design included two intervention arms (A and B), which were both preceded by a control observation period. In arm A, a com...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2003.00541.x

    authors： de Maat MM,de Boer A,Koks CH,Mulder JW,Meenhorst PL,van Gorp EC,Mairuhu AT,Huitema AD,Beijnen JH

    更新日期：2004-04-01 00:00:00

  • The safety of spironolactone treatment in patients with heart failure.

    abstract：INTRODUCTION:Spironolactone is increasingly being used in the treatment of heart failure. However, it has been associated with cases of hyperkalaemia. The common use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin-2 receptor (AT2) antagonists in heart failure increases the risk of hyperkalaemia. OBJE...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.1365-2710.2003.00491.x

    authors： Anton C,Cox AR,Watson RD,Ferner RE

    更新日期：2003-08-01 00:00:00

  • New medicines in primary care: a review of influences on general practitioner prescribing.

    abstract：BACKGROUND AND OBJECTIVE:The uptake of new medicines is slower in the UK than in many other countries. Previous research found that cost and price have little influence on general practitioner (GP) behaviour, but recent UK government policy may have heightened cost-consciousness. Focussing on new medicines, this review...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,评审

    doi：10.1111/j.1365-2710.2008.00875.x

    authors： Mason A

    更新日期：2008-02-01 00:00:00

  • Applications of population pharmacokinetics in current drug labelling.

    abstract：BACKGROUND AND OBJECTIVE:The application of population pharmacokinetics (PopPK) appears increasingly in drug labelling. The current study was to examine the use of PopPK in dose recommendation in drug-product labels. METHOD:PopPK information was identified in the data sheets included in the physician desk reference (P...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2007.00799.x

    authors： Duan JZ

    更新日期：2007-02-01 00:00:00

  • Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%).

    abstract：BACKGROUND AND OBJECTIVE:Moxifloxacin is a new fluorquinolone with broad-spectrum activity. It is suitable for treating peritonitis in peritoneal dialysis (PD) patients. The objective of this study was to test stability of moxifloxacin in PD solutions stored at different temperatures. METHODS:Dialysis solution bags we...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2006.00758.x

    authors： Fernández-Varón E,Marín P,Espuny A,Villamayor L,Escudero E,Cárceles C

    更新日期：2006-12-01 00:00:00

  • Selecting outcome parameters in studies aimed at improving rational use of antibiotics - practical considerations.

    abstract：:When designing studies of the optimal use of antimicrobial drugs, it is important to define at an early stage, which outcome parameters to use. It must be clear to which category a parameter to be measured belongs: the structure, the process or a clinical outcome. Attention must be paid to the measurement scales as we...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.0269-4727.2003.00518.x

    authors： Natsch S,Kullberg BJ,Hekster YA,van der Meer JW

    更新日期：2003-12-01 00:00:00

  • Determinants of prescribing costs amongst single-handed general practitioners.

    abstract：OBJECTIVE:To investigate the contribution of patient and doctor characteristics in explaining observed variations in prescribing costs between individual doctors. METHOD:Secondary analysis of data collected from general practitioners, Family Health Services Authorities, 1991 Census data set and the Prescription Pricin...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.1365-2710.2001.00371.x

    authors： Gill PS,Roalfe A

    更新日期：2001-12-01 00:00:00

  • Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Fluconazole is an antifungal agent that is commonly used to treat patients with serious systemic fungal infections in intensive care units. Fosfluconazole is a phosphate prodrug of fluconazole, which was developed to reduce the volume of fluid required to administer fluconazole by intravenou...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2011.01297.x

    authors： Aoyama T,Hirata K,Hirata R,Yamazaki H,Yamamoto Y,Hayashi H,Matsumoto Y

    更新日期：2012-06-01 00:00:00

  • Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Adverse drug events (ADE), common and underestimated in ICU patients, have direct consequences on length of stay, mortality and hospital costs. Critically ill patients with HIV/AIDS are at a high risk of ADE because of their need for multiple drug therapies. ADE can be prevented, especially ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12222

    authors： Ramos GV,Guaraldo L,Japiassú AM,Bozza FA

    更新日期：2015-02-01 00:00:00